Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.
Esophageal and oral carcinomas are relatively resistant to adenovirus serotype 5 (Ad5)-mediated gene transfer, primarily because expression of the cellular receptors for Ad5, the coxsackievirus and adenovirus receptor, is often downregulated in these types of tumor. The types of Ad in which the receptor expression is not suppressed in tumors are therefore better vectors for gene transfer into tumors. CD46, a cellular receptor for Ad subtype B2, such as Ad11 and Ad35, is well expressed in a number of esophageal and oral tumor cells. Since the infectivity of Ad to target cells is mainly influenced by the interaction between their fibers and the cellular receptors, we examined the infectivity of chimeric Ad5, whose fiber structure was substituted with that of type 11 or 35 (Ad5/11 or Ad5/35), to 6 human oral and 11 esophagus carcinoma cells. We found that the chimeric Ad, in particular Ad5/35, infected more effectively than Ad5 in all the tumors tested. However, the efficacy of Ad5/35- and Ad5/11-mediated transduction was not correlated with the expression level of CD46 or CD80/86, a cellular receptor of the Ad subtype B1, in the target cells. These data suggest that the Ad subtype B2 are suitable vectors of gene transfer for human squamous cell carcinomas of the upper gastrointestinal tract, and that the infectivity of the Ad subtype B2 can possibly be regulated by other receptors besides CD46.
Yu
Ling
L
Division of Pathology, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba 260-8717, Japan.
Takenobu
Hisanori
H
Shimozato
Osamu
O
Kawamura
Kiyoko
K
Nimura
Yoshinori
Y
Seki
Naohiko
N
Uzawa
Katsuhiro
K
Tanzawa
Hideki
H
Shimada
Hideaki
H
Ochiai
Takenori
T
Tagawa
Masatoshi
M
D000256:Adenoviridae / Q000235:genetics* / Q000472:pathogenicity*; D018122:B7-1 Antigen / Q000096:biosynthesis; D051940:B7-2 Antigen / Q000096:biosynthesis; D015152:Blotting, Northern; D002277:Carcinoma / Q000821:virology*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism; D045744:Cell Line, Tumor; D002469:Cell Separation; D015536:Down-Regulation; D004938:Esophageal Neoplasms / Q000378:metabolism / Q000821:virology*; D004947:Esophagus / Q000821:virology*; D005434:Flow Cytometry; D041981:Gastrointestinal Tract / Q000378:metabolism; D018014:Gene Transfer Techniques; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D051916:Membrane Cofactor Protein / Q000096:biosynthesis; D009062:Mouth Neoplasms / Q000378:metabolism / Q000821:virology*; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D012333:RNA, Messenger / Q000378:metabolism
D018122:B7-1 Antigen; D051940:B7-2 Antigen; D051916:Membrane Cofactor Protein; D012333:RNA, Messenger; D049452:Green Fluorescent Proteins